Hey,tigers!
The supplied screen contains 56 securities with issuer market capitalizations of at least $10 billion. Its quoted prices sit below the supplied intraday records, so this is a record-high watchlist. METAM is a preferred depositary security; BRK.A and BRK.B represent the same issuer. Screen prices, multiples and returns below are user-supplied, rather than independently verified market observations. Nasdaq
-
AI monetization faces a capital test:
MSFT’s accelerating Azure growth supports the AI infrastructure narrative, while AAPL offers exposure through devices and services. Meta’s financing adds a capital-structure dimension, although METAM’s conversion terms require separate analysis from common equity. Microsoft -
Payments deliver operating leverage:
V and MA reported double-digit revenue growth, with Mastercard also expanding margins. Their results support a structural digital-payments thesis, while the supplied valuations—36.3 times earnings for V and 35.2 times for MA—leave execution central to further gains. sec.gov -
Defensive growth broadens leadership:
KO’s volume growth, TMO’s organic recovery and AMGN’s expanding product sales provide earnings drivers beyond technology. Their presence suggests broader sector participation within this supplied watchlist. coca-colacompany.com -
Capital allocation matters alongside earnings:
Berkshire’s additional investment in Bending Spoons and Visa’s dividend increase highlight different routes to shareholder value. BRK.A and BRK.B should count as one underlying corporate exposure when assessing market breadth. sec.gov
1. $Apple(AAPL)$ — Apple Inc.
-
Core Business:
Consumer devices led by iPhone, alongside Mac, iPad, wearables and services spanning payments, subscriptions and digital distribution. -
Latest Developments:
Apple expanded its product cycle with iPhone Duo reaching stores in October. Ahead of earnings, BofA reiterated its positive stance on October 30, 2026. Apple (IE) -
Latest Earnings Highlights:
Q3 FY2026: Revenue reached $109.4 billion, up 16% YoY; diluted EPS rose 29% to $2.02. Gross margin was 50.1%, including approximately two percentage points from tariff refunds; refunds also added $0.11 to EPS. Apple -
Price Target Outlook:
On October 30, 2026, BofA Securities analyst Wamsi Mohan reiterated Buy with a $370 target. investors.com
2. $Microsoft(MSFT)$ — Microsoft Corporation
-
Core Business:
Enterprise cloud infrastructure, productivity software and AI platforms, alongside Windows, devices, advertising and gaming. -
Latest Developments:
On October 28, 2026, Microsoft reported Azure revenue of $33.17 billion, up 48% YoY, and commercial remaining performance obligations of $677 billion, up 73%. Microsoft -
Latest Earnings Highlights:
Q1 FY2027: Revenue increased 19% to $92.28 billion; operating income rose 21% to $45.92 billion. GAAP EPS was $4.92; adjusted EPS excluding OpenAI investment effects was $4.89, up 18%. Microsoft -
Price Target Outlook:
On October 29, 2026, Piper Sandler analyst Billy Fitzsimmons maintained Overweight, raising his target $610 → $650. streetinsider.com
3. $META PLATFORMS INC SER A DEPOSITARY SHS REP(METAM)$ — Meta Platforms, Inc., Series A Preferred Depositary Shares
-
Core Business:
Meta operates Facebook, Instagram, WhatsApp and Reality Labs. METAM represents a 1/20 interest in mandatory convertible preferred stock, with different economics from META common shares. Nasdaq -
Latest Developments:
In its pricing announcement posted October 27, 2026, Meta disclosed 250 million depositary shares at $50 each, representing a $12.5 billion offering with a 6.50% annual dividend rate on liquidation preference. Mandatory conversion is scheduled for approximately August 15, 2029, subject to the security’s terms. investor.atmeta.com -
Latest Earnings Highlights:
Issuer Q3 2026: Revenue rose 26% to $64.60 billion; operating margin was 20%, and diluted EPS was $3.83. Results included a $9.89 billion litigation charge; excluding it, company-disclosed EPS would have been $7.40. Meta Reports Third Quarter 2026 Results -
Price Target Outlook:
META common-share targets do not apply directly to METAM. Valuation requires the preferred security’s dividend and conversion terms; the supplied 1.7× P/E is excluded from comparison. investor.atmeta.com
4. $Berkshire Hathaway(BRK.B)$ — Berkshire Hathaway Inc., Class B
-
Core Business:
Diversified insurance, railroads, utilities, manufacturing, services and retailing, supported by a substantial investment portfolio. -
Latest Developments:
On October 29, 2026, Bending Spoons announced completion of Berkshire’s additional $330 million investment, taking its ownership to 4%, following a $600 million investment at the July IPO. sec.gov -
Latest Earnings Highlights:
Q2 2026: Operating earnings rose to $12.98 billion from $11.16 billion. Net earnings were $25.67 billion, or $11.91 per equivalent Class B share, including $12.68 billion of investment gains. sec.gov -
Price Target Outlook:
On October 22, 2026, UBS analyst Brian Meredith maintained Buy, raising his Class B target $604 → $628. Benzinga
5. $Berkshire Hathaway(BRK.A)$ — Berkshire Hathaway Inc., Class A
-
Core Business:
Class A shares provide exposure to the same consolidated businesses as BRK.B, with different share denomination and voting rights. -
Latest Developments:
The October 29, 2026, $330 million follow-on investment in Bending Spoons applies equally to the underlying business represented by Class A shares. sec.gov -
Latest Earnings Highlights:
Q2 2026: Net earnings per equivalent Class A share were $17,868, versus $8,601 a year earlier. Consolidated operating earnings were $12.98 billion; investment mark-to-market changes contributed to reported net earnings. sec.gov -
Price Target Outlook:
UBS maintained Buy on October 22, 2026, with its reported Class A target increasing $906,011 → $942,405. NYSE: BRKa Live - Investing.com
6. $Visa(V)$ — Visa Inc.
-
Core Business:
Global payment processing and network services connecting consumers, merchants and financial institutions, complemented by value-added services. -
Latest Developments:
On October 27, 2026, Visa increased its quarterly dividend 16% to $0.78 per share. Fiscal-year repurchases totaled $20.5 billion, with $24.4 billion of authorization remaining at September 30. sec.gov -
Latest Earnings Highlights:
Q4 FY2026: Net revenue increased 13% to $12.1 billion. GAAP EPS rose 22% to $3.19; adjusted EPS increased 17% to $3.48. sec.gov -
Price Target Outlook:
On October 28, 2026, Piper Sandler analyst Bill Carcache maintained Overweight, raising his target $430 → $479. TipRanks.com
7. $MasterCard(MA)$ — Mastercard Incorporated
-
Core Business:
Global payments infrastructure, supplemented by cybersecurity, analytics and other value-added services. -
Latest Developments:
On October 29, 2026, Mastercard reported purchase-volume growth of 9% and gross-dollar-volume growth of 7%, both in local currencies, alongside continued development of agentic commerce and its Global Money Platform. Earnings Release -
Latest Earnings Highlights:
Q3 2026: Revenue rose 14% to $9.8 billion. GAAP EPS increased 22% to $5.28; adjusted EPS rose 21% to $5.31, and adjusted operating margin reached 60.5%, versus 59.8% a year earlier. Earnings Release -
Price Target Outlook:
On October 30, 2026, Mizuho analyst Dan Dolev maintained Outperform, raising his target $666 → $711. streetinsider.com
8. $Coca-Cola(KO)$ — The Coca-Cola Company
-
Core Business:
Global beverage concentrates and brands spanning sparkling drinks, water, sports drinks, coffee, tea, juices and dairy. -
Latest Developments:
On October 27, 2026, Coca-Cola raised its full-year guidance and reported $11.4 billion of year-to-date free cash flow. Global unit-case volume increased 5%, including 16% growth for Coca-Cola Zero Sugar. coca-colacompany.com -
Latest Earnings Highlights:
Q3 2026: Revenue rose 7% to $13.4 billion. Operating margin expanded 32.0% → 33.4%; GAAP EPS increased 8% to $0.93, while comparable EPS rose 11% to $0.91. coca-colacompany.com -
Price Target Outlook:
In an update reported October 28, 2026, UBS analyst Peter Grom maintained Buy, raising his target $104 → $106. benzinga.com
9. $Thermo Fisher Scientific(TMO)$ — Thermo Fisher Scientific Inc.
-
Core Business:
Laboratory instruments, diagnostics, consumables and pharmaceutical services serving research institutions, healthcare providers and biopharmaceutical companies. -
Latest Developments:
On October 21, 2026, Thermo Fisher highlighted its Mayo Clinic Precure initiative, combining data from more than one million patient samples with its proteomics technologies. It also confirmed completion of its microbiology-business divestiture during the quarter. ir.thermofisher.com -
Latest Earnings Highlights:
Q3 2026: Revenue increased 9% to $12.14 billion, including 6% organic growth. Adjusted EPS rose 15% to $6.68, while adjusted operating margin expanded 23.3% → 24.5%; GAAP EPS was $4.64. ir.thermofisher.com -
Price Target Outlook:
On October 22, 2026, TD Cowen analyst Dan Brennan maintained Buy, raising his target $760 → $810. TipRanks.com
10. $Amgen(AMGN)$ — Amgen Inc.
-
Core Business:
Biotechnology medicines spanning oncology, inflammation, cardiovascular disease, bone health and rare diseases. -
Latest Developments:
On October 28, 2026, Amgen scheduled its third-quarter earnings release for November 3, 2026, after market close. Those results fall outside this article’s cutoff. amgen.com -
Latest Earnings Highlights:
Q2 2026: Revenue increased 10% to $10.1 billion. GAAP EPS rose 65% to $4.37; adjusted EPS increased 4% to $6.29. Free cash flow reached $3.5 billion, versus $1.9 billion a year earlier. sec.gov -
Price Target Outlook:
On October 8, 2026, RBC Capital analyst Luca Issi maintained Outperform, raising his target $400 → $430. That target sits below the supplied $478.48 screen price.
For discussion and education only. Dollar figures are U.S. dollars. The nearly 3% decline is Reuters’ November 2 after-hours reporting snapshot, not a final session return. Company guidance and editorial scenarios are forward-looking; actual outcomes may differ.
Comments